1.
Effects of ginger on serum glucose, advanced glycation end products, and inflammation in peritoneal dialysis patients
by Imani, Hossein, Ph.D
Nutrition (Burbank, Los Angeles County, Calif.), 2015, Vol.31 (5), p.703-707
2.
Nutrition in children with CRF and on dialysis
by Rees, Lesley
Pediatric nephrology (Berlin, West), 2007, Vol.22 (10), p.1689-1702
3.
Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure
by Ortiz, Alberto, Prof
The Lancet (British edition), 2014, Vol.383 (9931), p.1831-1843
4.
Regimen Complexity and Prescription Adherence in Dialysis Patients
by Neri, Luca
American journal of nephrology, 2011, Vol.34 (1), p.71-76
5.
Worldwide access to treatment for end-stage kidney disease: a systematic review
by Liyanage, Thaminda, MBBS
The Lancet (British edition), 2015, Vol.385 (9981), p.1975-1982
6.
Factors affecting outcomes in patients reaching end-stage kidney disease worldwide: differences in access to renal replacement therapy, modality use, and haemodialysis practices
by Robinson, Bruce M, Dr
The Lancet (British edition), 2016, Vol.388 (10041), p.294-306
7.
Prevalence of Pre-End-Stage Renal Disease Care and Associated Outcomes among Urban, Micropolitan, and Rural Dialysis Patients
by Maripuri, Saugar
American journal of nephrology, 2013, Vol.37 (3), p.274-280
8.
Effect of intensive nutritional counseling and support on clinical outcomes of hemodialysis patients
by Molfino, Alessio, M.D., Ph.D
Nutrition (Burbank, Los Angeles County, Calif.), 2012, Vol.28 (10), p.1012-1015
9.
Baclofen Toxicity in Patients with Advanced Nephropathy: Proposal for New Labeling
by El-Husseini, Amr
American journal of nephrology, 2011, Vol.34 (6), p.491-495
10.
Disparities in dialysis treatment and outcomes for Dutch and Belgian children with immigrant parents
by Schoenmaker, Nikki J
Pediatric nephrology (Berlin, West), 2012, Vol.27 (8), p.1369-1379
11.
Autosomal dominant polycystic kidney disease
by Torres, Vicente E, MD
The Lancet (British edition), 2007, Vol.369 (9569), p.1287-1301
12.
Lessons learned from efforts to improve the quality of care in children with end-stage renal disease in the Netherlands and Belgium
by Tromp, Wilma F
Archives of Disease in Childhood, 2011, Vol.96 (12), p.1093-1096
13.
Bioengineered human acellular vessels for dialysis access in patients with end-stage renal disease: two phase 2 single-arm trials
by Lawson, Jeffrey H, MD PhD
The Lancet (British edition), 2016, Vol.387 (10032), p.2026-2034
14.
Dose adjustment of carboplatin in patients on hemodialysis
by Guddati, Achuta K
Medical oncology (Northwood, London, England), 2014, Vol.31 (3), p.848
16.
Lupus Nephritis and End-stage Kidney Disease
by Maroz, Natallia, MD
The American journal of the medical sciences, 2013, Vol.346 (4), p.319-323
17.
Racial Differences in Clinical Use of Cinacalcet in a Large Population of Hemodialysis Patients
by Newsome, Britt B
American journal of nephrology, 2013, Vol.38 (2), p.104-114
18.
Study of Heart and Renal Protection (SHARP): Randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease
by Group, Sharp Collaborative
The American heart journal, 2010, Vol.160 (5), p.785-794.e10
19.
The dietary management of calcium and phosphate in children with CKD stages 2-5 and on dialysis—clinical practice recommendation from the Pediatric Renal Nutrition Taskforce
by McAlister, Louise
Pediatric nephrology (Berlin, West), 2019, Vol.35 (3), p.501-518
20.
Approaches to Prolong the Use of Uncuffed Hemodialysis Catheters: Results of a Randomized Trial
by Filiopoulos, Vassilis
American journal of nephrology, 2011, Vol.33 (3), p.260-268
